AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05569382 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1. week: uptitration with one capsules per day, until maximum dosage of three capsules/day.~2-4. week: steady state treatment with the maximum tolerated dose.~5. week: downtitration
Study NCT04926259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-T807
Description: Intravenous injection of one dose of 10mCi (370MBq, ±5%) 18F-T807. Each subject receive a single intravenous injection of 18F-T807, and undergo PET/CT imaging within the specificed time.
Study NCT05500300 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neo-Russian
Description: Subjects will receive Neo-Russian electrical stimulation with three reps (5 sec work x 60 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured.~They will be asked how uncomfortable the stimulation was, using Visual Analogue Scale (VAS).~One week later, subjects will receive a fatigue protocol that consists in 21 reps (5 sec work x 5 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured for each contraction.
Study NCT05500300 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aussie
Description: Subjects will receive Aussie electrical stimulation with three reps (5 sec work x 60 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured.~They will be asked how uncomfortable the stimulation was, using Visual Analogue Scale (VAS).~One week later, subjects will receive a fatigue protocol that consists in 21 reps (5 sec work x 5 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured for each contraction.
Study NCT05500300 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RBS
Description: Subjects will receive RBS electrical stimulation with three reps (5 sec work x 60 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured.~They will be asked how uncomfortable the stimulation was, using Visual Analogue Scale (VAS).~One week later, subjects will receive a fatigue protocol that consists in 21 reps (5 sec work x 5 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured for each contraction.
Study NCT05500300 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RBS-IPI
Description: Subjects will receive RBS-IPI electrical stimulation with three reps (5 sec work x 60 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured.~They will be asked how uncomfortable the stimulation was, using Visual Analogue Scale (VAS).~One week later, subjects will receive a fatigue protocol that consists in 21 reps (5 sec work x 5 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured for each contraction.
Study NCT05500300 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HIFEM
Description: Subjects will receive HIFEM electrical stimulation with three reps (5 sec work x 60 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured.~They will be asked how uncomfortable the stimulation was, using Visual Analogue Scale (VAS).~One week later, subjects will receive a fatigue protocol that consists in 21 reps (5 sec work x 5 sec rest), and the Maximal Electrical Induced Contraction (MEIC) will be measured for each contraction.
Study NCT05797844 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active implementational educational strategy
Description: 4 follow-up visits (active implemantation strategy) were carried out for ETT cuff pressure management using the one-on-one demonstration technique every 21 days. These follow-ups included adherence to evidence-based guidelines, nurses' application of endotracheal cuff pressure measurement and solving the problems encountered during its implementation. Uncertainties associated with evidence-based guidance on endotracheal tube cuff pressure control were clarified during these sessions.
Study NCT05797844 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Passive implementational educational strategy
Description: Theoretical training on endotracheal tube cuff pressure management through a 4-hour presentation prepared with evidence-based guide and literature. A PowerPoint presentation including endotracheal tube cuff pressure normal values, complications related to endotracheal tube cuff pressure, management of endotracheal tube cuff pressure, endotracheal tube cuff pressure control methods, methods affecting endotracheal tube cuff pressure, how to measure endotracheal tube cuff pressure was made.
Study NCT05797844 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive implementational educational strategy
Description: Theoretical training on endotracheal tube cuff pressure management through a 4-hour presentation prepared with evidence-based guide and literature. A PowerPoint presentation including endotracheal tube cuff pressure normal values, complications related to endotracheal tube cuff pressure, management of endotracheal tube cuff pressure, endotracheal tube cuff pressure control methods, methods affecting endotracheal tube cuff pressure, how to measure endotracheal tube cuff pressure was made.
Study NCT04689152 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cellgram-LC
Description: Patients will receive single injection of Cellgram-LC(mesenchymal stem cell) hepatic artery.
Study NCT06279702 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SERIOUS GAME
Description: Students will play serious game that about first aid.
Study NCT06279702 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COMICS
Description: students will learn comics that about first aid.
Study NCT05896787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104, nab-paclitaxel, carboplatin
Description: AK104 plus nab-paclitaxel and carboplatin as neoadjuvant therapy，and AK104 as adjuvant therapy for those who do not achieve pCR;
Study NCT06427694 — intervention group
Intervention type: DRUG
Intervention: Aldesleukin
Description: IL2 antagonist
Study NCT06427694 — intervention group
Intervention type: DRUG
Intervention: Dextrose 5% in water
Description: matched placebo to active
Study NCT04798040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cold application
Description: To reduce pain, cold application is applied around the drain before the drain is removed.
Study NCT04798040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: lavender oil inhalation
Description: To reduce pain, lavender oil is inhaled prior to drain removal.
Study NCT04798040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: oxygen administration
Description: To reduce pain, oxygen is inhaled prior to drain removal.
Study NCT05553275 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Blood sugar evaluation (accuchecks) every four hours in latent labor and every 2 hours in active labor.Participants will be routinely managed with maintenance fluids of lactated ringers during latent labor and lactated ringers with dextrose 5% in active labor. Blood sugars of more than 110 mg/dl at any time point in labor will be treated with an insulin drip as follows:~Regular insulin (100 units) in 100cc of normal saline, with Lactated Ringers with 5% dextrose at 125cc/hour. If blood sugar 111-140, insulin drip at 1 unit/hour will be given and continued if blood sugar is 111-140.If blood sugar is 141-180, then drip will be changed to to 1.5 unit/hour and if blood sugar is 181-220, drip will be changed to 2.0 units/hour and MD will be called if blood sugar is more than 221 mg/dl
Study NCT05553275 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Permissive intrapartum glucose control
Description: Blood sugar evaluation (accuchecks) every four hours in latent labor and every 2 hours in active labor.Participants will be routinely management with maintenance fluids of lactated ringers during latent labor and lactated ringers with dextrose 5% in active labor.Blood sugars of more than 180 mg/dl at any time point in labor will be treated with an insulin drip as follows:~Regular insulin (100 units) in 100cc of normal saline, with Lactated Ringers with 5% dextrose at 125cc/hour.If blood sugar is 181-200, insulin drip at 1 unit/hour will be given. If blood sugar is 201-220, then drip will be changed to 1.5 units/hour. If blood sugar is 221 - 250, then drip will be changed to 2.0 units/hour and if blood sugar is more than 251 MD will be called.
Study NCT05208775 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PDT
Description: Drug: (Hematoporphyrin sodium injection) Hematoporphyrin sodium injection (xibofen):2mg/kg I.V.~Laser irradiation:~48 hours after the patient input the photosensitizer, the laser irradiation time is 900 seconds, and the output power is 200 watts.
Study NCT05208775 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ESD
Description: The patients received standard endoscopic submucosal dissection after enrollment.
Study NCT04905940 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Turmeric mouthwash
Description: Turmeric mouthwash evaluation in controlling halitosis
Study NCT04905940 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Turmeric mouthwash
Description: Turmeric mouthwash evaluation in controlling halitosis
Study NCT04905940 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Turmeric mouthwash
Description: Turmeric mouthwash evaluation in controlling halitosis
Study NCT04683224 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UB-612
Description: 100 µg \[microgram\] of an experimental study vaccine
Study NCT04683224 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is a 0.9% sodium chloride (normal saline) injection
Study NCT05534061 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Connect2Test
Description: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
Study NCT05534061 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Connect2Test
Description: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
Study NCT05430217 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buspirone
Description: 1 tablet (15 mg) once per day for 28 days
Study NCT05430217 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 placebo tablet once per day for 28 days
Study NCT06241469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab,nab-paclitaxel and tegio
Description: Immunotherapy combined with chemotherapy
Study NCT05698433 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06598241 — intervention group
Intervention type: DEVICE
Intervention: Borate-base Bioactive Glass Fiber Matrix (BBGFM)
Description: Bioactive glass materials are biocompatible water-soluble inorganic ceramic materials that release their constituent ions when immersed in body fluids.
Study NCT06622642 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transoral technique for mandibular angle fracture reduction
Description: In transoral technique approach inferior alveolar nerve block and buccal nerve block will be given by 2% xylocaine with 1:100000 adrenaline. Incision will be made with surgical blade no 15 from gingival crevices of molars to ascending ramus. Fracture segments will be reduced alongwith MMF. A 5-hole 2mm miniplate with 2 holes anterior and 2 holes posterior to fracture line will be screwed to external oblique ridge and MMF will be removed and incision line will be closed.
Study NCT06622642 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transbuccal technique for mandibular angle fracture reduction
Description: In transbuccal technique inferior alveolar nerve block and buccal nerve block will be given by 2% xylocaine with 1:100000 adrenaline. Incision will be made with surgical blade no 15 from gingival crevices of molars to ascending ramus. Fracture segments will be reduced alongwith MMF. extraorally a stab incision will be made with scalpel blade parallel to relaxed resting skin tension lines through which the cannula with a trocar will be inserted through facial tissue down to bone. Transbuccal instrument system will cionsist of transbuccal guide, mountable retractor, drill sleeve, drill guide, and 2mm drill bit. A 2mm titanium miniplate will be placed along buccal cortex and screwed through trocar system. MMF will be removed and incision line closed
Study NCT06633835 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: protein subunit: Novavax COVID-19 vaccine
Description: Participants will receive a single dose (0.5 ml) of study vaccine Novavax COVID-19 vaccine, 2024-2025 formula (JN.1 containing) in the deltoid muscle of the arm.
Study NCT06633835 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Pfizer mRNA COVID-19 vaccine
Description: Participants will receive a single dose (0.3 ml) of study vaccine Pfizer mRNA COVID-19 vaccine, 2024-2025 formula (KP.2 containing) in the deltoid muscle of the arm.
Study NCT05149326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN046
Description: KN046+Nab-Paclitaxel+Gemcitabine In combine therapy stage, KN046 is 5 milligram per kilogram, every 2 weeks. In maintain stage, KN046 is 5 milligram per kilogram, every 2 weeks.
Study NCT05149326 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo+Nab-Paclitaxel+Gemcitabine In combine therapy stage, placebo is 5 milligram per kilogram, every 2 weeks. In maintain stage, placebo is 5 milligram per kilogram, every 2 weeks.
Study NCT05961917 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 5 cmH2O Positive end-expiratory pressure (PEEP)
Description: PEEP will be set at 5 cmH2O
Study NCT04946617 — intervention group
Intervention type: DRUG
Intervention: undefined
Description: Rinsing with mouthwashes
Study NCT05772078 — intervention group
Intervention type: OTHER
Intervention: Assess compliance rate and demographics
Description: Records to evaluate attendance rate
Study NCT04788771 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Tracheal intubation in laparoscopic extraperitoneal hernia repair
Description: laryngeal mask airway in laparoscopic extraperitoneal hernia repair
Study NCT04788771 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tracheal intubation in laparoscopic extraperitoneal hernia repair
Description: laryngeal mask airway in laparoscopic extraperitoneal hernia repair
Study NCT05961917 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 10 cmH2O Positive end-expiratory pressure (PEEP)
Description: PEEP will be set at 10 cmH2O
Study NCT04100434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evolocumab
Description: Patients were randomly assigned of the ratio of 1:1 using a computer-generated random number and divided into two treatment groups: the statin alone therapy and the evolocumab plus statin therapy.
Study NCT05236712 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile app
Description: The app sends reminder 'push' notifications to complete weekly surveys. The survey is a series of questions about foods and drinks participants had in the last week. Once the weekly survey is completed the app generates a personalized weekly report showing foods we encourage participants to eat more of, eat less of, or keep eating the same amount of. The app will also show menu recommendations for breakfast, lunch, dinner, and snacks that will help participants to eat healthier. Finally, the app also has a feature that allows chatting with the research team by sending and receiving in-app texts.
Study NCT05013970 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Clinical assessment
Description: Clinical assessment including Visual Analog Scale (VAS) for Knee Pain, and Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire
Study NCT05013970 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Radiographic imaging
Description: MRI of the knee
Study NCT05153707 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Discharge Education Program
Description: medication reconciliation, medication review, individually prepared patient medicine (pill) card, patient education (based on Health Belief Model by using written material and video, and verbally \[by using Teach back method especially for patients with low health literacy\]) and counseling (using behavior change techniques based on The Capability, Opportunity, and Motivation Behavior model).
Study NCT04795700 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MSC intervention
Description: Patients in the intervention group had access to conventional care, in addition to receiving the 8 weeks MSC intervention sessions. The intervention was provided by trained nurses, including one researcher and one MSC therapist. The intervention is mainly out-of-hospital intervention, supplemented by short-term in-hospital intervention. Among them, the first and second weeks of the intervention project in the hospital phase focus on guiding the research subjects to understand the content of mindful self-compassion and emotions, and carry out basic mindful self-compassion training; the content of the 3-8th week of the intervention program outside the hospital, Focus on the maintenance of mindful self-compassion training and the promotion of mindful life. Each face-to-face group contact lasted about 1 hour, depending on the complexity of the patients' problems.
Study NCT06256146 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food allergy desensitization / Oral Immunotherapy
Description: Participants consume increasing doses of allergenic food daily until they reach a maintenance dose. In the case of the High Dose Arm, participants will progress to a daily dose of either 1200 mg, 300 mg or 200 ml of egg, peanut or milk respectively.~Participants randomized to the Low Dose Arm also begin by consuming small amounts of the allergenic food, gradually increasing the daily dose. However, participants in this group only progress to 300 ml, 30 mg or 50 ml daily dose of egg, peanut or milk respectively.~The Cooked/Transformed Allergen Arm begins the desensitization with a cooked or transformed form of the allergen - muffins in the case of egg or milk, Bamba puffs in the case of peanut. Participants take increasing amounts of these products (one muffin for egg and milk and four Bamba puffs for peanut) then transition to egg, milk or peanut. Participants then continue their dose progression, getting to 1200 mg, 200 ml or 300 mg for egg, milk and peanut respectively.
Study NCT05121285 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Delivery of contrast fluid by lower GI endoscopy
Description: Each participant will receive one delivery of 440 ml contrast fluid by lower GI endoscopy to the cecum of the colon. The participants perform a bowel lavage using Sodiumpicosulphate/Magnesiumcitrate (Picoprep, Ferring) 24 hours before the delivery of contrast fluid. An colon X-ray is obtained within 10 minutes after the contrast fluid is delivered. The participants is in a supine position fram delivery and until the colon x-ray is obtained.
Study NCT05121285 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Delivery of contrast fluid by enema with and without positioning
Description: Each participant will receive one delivery of 440 ml contrast fluid by enema. The participants perform a bowel lavage using Sodiumpicosulphate/Magnesiumcitrate (Picoprep, Ferring) 24 hours before the delivery of contrast fluid. The enema procedure includes:~1. The participant lies on his/her left side in neutral position when the enema is delivered~2. X-ray of the colon is obtained with the participant lying on his/her back.~3. The participant is positioned back to his/her left sided position and tilted in a Trendelenburg position. The position is held for two minutes~4. The participant is turned to an abdominal position while the bed remains tilted in Trendelenburg position.~5. Participant turne to the right side. When positioned the bed is tilted the opposite way (anti-Trendelenburg.) The position is held for two minutes.~6. A second colon X-ray is obtained after the participants has rested for ten minutes in a supine neutral position
Study NCT03824756 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NGO supported GMP program
Description: An International NGO has signed a contract with Government to support in implementing the growth Monitoring and Promotion (GMP) program. This program will be implemented at Community clinics. It will ensure the sustainability of community clinics in the selected areas through capacity building and follow up with community groups, community support groups, and Government Health and Family Planning service providers.
Study NCT03824756 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non-supported GMP program
Description: This is control arm of the study. In this arm, there will be Government's usual GMP program implemented at community clinics without any NGO support.
Study NCT04833972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey questionnaire
Description: Each version of the questionnaire has the same questions about perceived norms about substance use in the community but differs in how the response options are offered.
Study NCT05341609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JT001
Description: Day 1: 600mg, Q12H X 1 day; Day 2\~5: 300mg, Q12H X 4 days
Study NCT05341609 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paxlovid
Description: Day 1\~5: 300 mg of Nirmatrelvir and 100 mg of ritonavir, Q12H X 5 days
Study NCT05458453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: Self-controlled intravenous analgesia pump was used for continuous injection, and it was prepared according to sufentanil 1.5ug/ml+ esketamine 0.75ug/ml+16mg ondansetron. After the operation, the analgesic pump was connected, and sufentanil 0.1ug/kg/h+ esketamine 0.05mg/kg/h was pumped continuously for 24 hours. The continuous infusion of analgesia pump is (kg body weight/15) ml/h. (e.g. 60kg, pump speed 4ml/h, total amount 96ml).